Development of Sarcoidosis Following Completion of Treatment for Hepatitis C with Pegylated Interferon-alpha 2a and Ribavirin: A Case Report and Literature Review

被引：17
|
作者：
Gayet, Alberic-Rembrandt [1 ]
Plaisance, Patrick [1 ]
Bergmann, Jean-Francois [2 ]
Mouly, Stephane [2 ]
机构：
[1] Lariboisiere Hosp, AP HP, Emergency Dept, Paris, France
[2] Lariboisiere Hosp, AP HP, Dept Internal Med, Paris, France
来源：
CLINICAL MEDICINE & RESEARCH | 2010年 / 8卷 / 3-4期
关键词：
Chronic hepatitis C; Interferon-alpha and ribavirin combination therapy; Sarcoidosis; Spontaneous recovery;
D O I：
10.3121/cmr.2010.886
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sarcoidosis is a chronic inflammatory multisystem disease of unknown etiology. We report on a woman, aged 57 years, presenting with typical sarcoidosis occurring two months after completion of a six-month course of interferon-a and ribavirin for chronic hepatitis C virus infection. The current observation is interesting with regard to the time elapsed between the occurrence of symptoms and antiviral treatment withdrawal, and spontaneous recovery after ten months of follow-up. Pathophysiological mechanisms involved in the development of antiviral therapyinduced sarcoidosis are discussed.
引用
收藏
页码：163 / 167
页数：5
相关论文
共 50 条
  • [21] Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response
    Carlsson, T
    Reichard, O
    Norkrans, G
    Bläckberg, J
    Sangfelt, P
    Wallmark, E
    Weiland, O
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (05) : 473 - 480
  • [22] Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon-alpha and ribavirin
    Striki, A.
    Manolakopoulos, S.
    Deutsch, M.
    Mela, M.
    Kalafateli, M.
    Schini, M.
    Anagnostou, O.
    Triantos, C.
    Andreadis, I.
    Ketikoglou, I.
    Papatheodoridis, G.
    Pectasides, D.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (09) : 624 - 632
  • [23] Papular Sarcoidosis of the Knees Following Treatment with Interferon Alpha and Ribavirin in a Woman with Hepatitis C
    Monteagudo, B.
    Grueiro, M. C.
    Vilas-Sueiro, A.
    Campo-Cerecedo, F.
    ACTAS DERMO-SIFILIOGRAFICAS, 2019, 110 (10): : 871 - 873
  • [24] Reactivation of Pulmonary and Cutaneous Sarcoidosis after Treatment for Chronic Hepatitis C with Pegylated Interferon Alpha and Ribavirin
    Fathallah, N.
    Zamy, M.
    Slim, R.
    Bouraoui, K.
    Ben Salem, C.
    Biour, M.
    DRUG SAFETY, 2011, 34 (10) : 947 - 948
  • [25] Comparision of the Side Effects Due To Interferon Alpha 2A Plus Ribavirin and Pegylated Interferon Alpha 2A Plus Ribavirin Combinations For Chronic Hepatitis C Infection
    Ural, Onur
    Demir, Nazlim Aktug
    Sumer, Sua
    Ural, Gaye
    Balci, Mehmet
    TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2010, 27 (03): : 261 - 264
  • [26] Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature
    Lopez, Veronica
    Molina, Inmaculada
    Monteagudo, Carlos
    Jorda, Esperanza
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2011, 50 (03) : 287 - 291
  • [27] Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C
    Marangon, A. V.
    Moliterno, R. A.
    Sell, A. M.
    de Moraes, C. F. V.
    Grotto, R. M. T.
    Pardini, M. C.
    De Pauli, D. S.
    Visentainer, J. E. L.
    Silva, G. F.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2012, 39 (04) : 296 - 302
  • [28] Safety and efficacy of pegylated interferon α-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia
    Harmatz, Paul
    Jonas, Maureen M.
    Kwiatkowski, Janet L.
    Wright, Elizabeth C.
    Fischer, Roland
    Vichinsky, Elliott
    Giardina, Patricia J.
    Neufeld, Ellis J.
    Porter, John
    Olivieril, Nancy
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (08): : 1247 - 1251
  • [29] Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
    Leung, Yvette
    Urbanski, Stefan J.
    Schindel, Lynn
    Myers, Robert P.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 20 (10) : 661 - 663
  • [30] Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin
    Weegink, CJ
    Chamuleau, RAFM
    Reesink, HW
    Molenaar, DSM
    JOURNAL OF GASTROENTEROLOGY, 2001, 36 (10) : 723 - 724
12345